fda warning letters glp-1 compounders september 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading FDA Issues Warnings Against Illegal
Description
Weight loss entails many health benefits that go beyond the scale, and GLP-1s have been shown to alleviate the symptoms of many medical conditions such as diabetes and cardiovascular issues
These individual stories are encouraging, but theyre exactly that: individual stories
Different drugs, different risks
Ethics declarations Ethics Approval Waived for narrative review Non-applicable
Genetic insights should always be interpreted with a qualified healthcare provider and never used in isolation
